Compare AbbVie Inc (ABBV) vs VanEck Video Gaming and eSports ETF (ESPO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbbVie Inc vs VanEck Video Gaming and eSports ETF — how do they compare? AbbVie Inc trades at $253.93 (market cap $449.91B), while VanEck Video Gaming and eSports ETF trades at $92.17. The key difference: AbbVie Inc pays a 2.72% dividend while VanEck Video Gaming and eSports ETF pays none, and AbbVie Inc is trading nearer its 52-week high, VanEck Video Gaming and eSports ETF nearer its low. Which is the better fit depends on your goals.
| ABBV | ESPO | |
|---|---|---|
Market Cap | $449.91B | — |
Sector | Health | Sector/Thematic |
52-Week High | $261.07 | $122.30 |
52-Week Low | $184.85 | $85.25 |
Enterprise Value | $513.38B | — |
Dividend Yield | 2.72% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbbVie (ABBV) trades at $252.92, down 0.72% on the day, with strong technical support at $251 and resistance at $258. The stock shows bullish momentum with recent earnings beats and a consensus analyst price target of $266.33. Revenue grew to $61.16B in 2025, though net margins compressed to 5.79%. Key growth drivers include Skyrizi and Rinvoq offsetting Humira declines, supported by positive Phase 2 data for ELAHERE in ovarian cancer (PRNewsWire, 2026-04-12).
Outlook remains positive with immunology portfolio strength and dividend growth, but risks include patent cliffs in the 2030s and high debt levels. Institutional buying and 68% analyst buy ratings suggest confidence, though valuation multiples like P/E of 124.83 warrant caution. Near-term catalysts include Q2 2026 earnings expected at $3.79 EPS.
ESPO (VanEck Video Gaming and eSports ETF) trades at $92.89, up 1.04% with bullish technical signals from moving averages. The ETF benefits from AI-driven gaming industry growth potential, with institutional interest shown by Assetmark's 35.9% position increase. Technical indicators show strong trend momentum despite overbought short-term RSI conditions.
The gaming ETF presents exposure to digital entertainment's structural growth, with AI potentially unlocking $22B in industry profits. Key risks include thematic ETF volatility and gaming sector competition. Support at $91-$92 levels provides near-term technical foundation for the current bullish trend.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About VanEck Video Gaming and eSports ETF
ESPO is a thematic ETF that invests in the global video gaming and eSports industry. It provides exposure to companies involved in game development, hardware, and streaming, including major firms like Tencent, Nintendo, and Electronic Arts.
Read more on ESPO →
